Also great if true

BBC NEWS | Health | Drug may reverse MS brain damage

The latest three-year study, of 334 patients with relapsing-remitting MS which had yet to be treated, found that the drug cut the number of attacks of disease by 74% more than the reduction achieved by conventional interferon-beta therapy.

Alemtuzumab also reduced the risk of sustained accumulation of disability by 71% compared to beta-interferon.

People on the trial who received the drug also recovered some function that had been thought to be permanently lost, and as a result were less disabled after three years than at the beginning of the study

The NHS don’t want to use it because of the side effects (including death), but I can sure think of a lot of patients who would want to take that risk.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s


%d bloggers like this: